Compare WLK & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLK | HSIC |
|---|---|---|
| Founded | 1986 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 9.7B |
| IPO Year | 2004 | 1996 |
| Metric | WLK | HSIC |
|---|---|---|
| Price | $70.33 | $85.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $106.87 | $85.07 |
| AVG Volume (30 Days) | 975.2K | ★ 1.2M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 7.21 |
| EPS | N/A | ★ 0.92 |
| Revenue | $11,170,000,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $5.51 | $6.12 |
| Revenue Next Year | $3.74 | $3.64 |
| P/E Ratio | ★ N/A | $92.59 |
| Revenue Growth | N/A | ★ 5.94 |
| 52 Week Low | $56.33 | $61.97 |
| 52 Week High | $124.23 | $89.34 |
| Indicator | WLK | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 24.28 | 54.78 |
| Support Level | $56.33 | $82.77 |
| Resistance Level | $79.57 | $88.78 |
| Average True Range (ATR) | 2.17 | 1.84 |
| MACD | -0.17 | -0.38 |
| Stochastic Oscillator | 9.33 | 37.38 |
Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.